Clinical trials
Rectal Fistula trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 6 |
| Terminated | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cook Group Incorporated | 3 |
| Mayo Clinic | 2 |
| Alexander Hawkins | 1 |
| Aroa Biosurgery Limited | 1 |
| Colon and Rectal Surgery Associates, Ltd. | 1 |
| ECM Therapeutics, Inc. | 1 |
| RedDress Ltd. | 1 |
| Rush University Medical Center | 1 |
| Sanford Health | 1 |
| Signum Surgical USA Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rectal Fistula | 20 |
| Crohn Disease | 3 |
| Addison Disease | 1 |
| Alagille Syndrome | 1 |
| Alstrom Syndrome | 1 |
| Amnesia, Transient Global | 1 |
| Aniridia | 1 |
| Ataxia | 1 |
| Ataxia Telangiectasia | 1 |
| Atypical Hemolytic Uremic Syndrome | 1 |
Trials
Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.